Navigation Links
Ralf Rosskamp, M.D. Joins Biodel's Scientific Advisory Board
Date:8/22/2007

DANBURY, Conn., Aug. 22 /PRNewswire-FirstCall/ -- Biodel, Inc. (Nasdaq: BIOD) today announced the addition of Ralf Rosskamp, M.D., to its Scientific Advisory Board (SAB).

Dr. Rosskamp was previously the Executive Vice President of Research and Development at Kos Pharmaceuticals, where he managed all research and development activities until Kos was acquired by Abbott Laboratories. Dr. Rosskamp's accomplishments at Kos include building an integrated research and development organization, globally expanding Kos's clinical research organization and assisting in the approval of four supplemental new drug applications.

"We are extremely honored to have Dr. Rosskamp join our SAB," said Dr. Solomon Steiner, CEO and Chairman of Biodel. "Dr. Rosskamp played an integral role in bringing insulin analogs to the market. His wealth of knowledge and clinical experience in the field of endocrinology will significantly contribute to the development of VIAject(TM), VIAtab(TM) and our two osteoporosis product candidates."

"I am delighted to join Biodel's SAB, especially at such an exciting time for the Company," said Dr. Rosskamp. "Biodel has created an innovative, injectable human insulin for diabetics and has made great progress in the clinical development of VIAject(TM). I look forward to collaborating with the Biodel team in their efforts to bring safer and more effective treatments to the diabetic patient population."

Prior to joining Kos, Dr. Rosskamp held prominent positions for thirteen years at Aventis Pharmaceuticals, a lead-developer of endocrinology products. At Aventis, Dr. Rosskamp was responsible for achieving FDA/EMEA approval of Lantus(R), the best-selling basal insulin analog and coordinating the clinical trials for Apidra(R), a rapid-acting insulin analog. In addition, Dr. Rosskamp managed the approval process for Actonel(R) Once-a-Week, which prevents and treats post-menopausal osteoporosis, and aided in completing the Phase III study
'/>"/>

SOURCE Biodel, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Chemical-petroleum executive joins Virent Energy board
2. Schneider National exec joins TrafficCast board
3. Doyle joins governors in support of stem cell bill
4. Genomics researcher Hood joins NimbleGen board
5. Fergus joins Baird Venture Partners, Caden Bio
6. Meier joins Broadlook Technologies as COO
7. Prodesse joins forces with Invitrogen
8. Wisconsin joins price-fixing suit vs. D-RAM makers
9. Napier joins board of Third Wave Technologies
10. Schmidt rejoins Renaissance Learning
11. Tommy Thompson joins drug company as advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... a new study led by George Washington University ... nucleation of ice in small droplets is strongly ... at the nanoscale. The formation of ice at ... question whose answer also has important implications for ... crystallization of ice from supercooled water is generally ...
(Date:5/21/2013)... May 21, 2013 Clinverse, ... company for clinical trials, announced today it has ... LLC. Clinverse’s ClinPay® FLS eClinical commerce platform ... process. SpendMD ™, Aggregate Spend Solutions’ ... for tracking and reporting transfer of value at ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
Breaking Biology Technology:FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2
... Feb. 7 deCODE genetics,(Nasdaq: DCGN ) today ... deCODE,Chief Scientific Officer Jeffrey Gulcher,s presentation at Biotechnology,Industry Organization ... be delivered at 2:45 PM ET / 19:45GMT on ... The webcast can be,accessed through the Investors page on ...
... ATLANTA, Feb. 7 CryoLife, Inc., (NYSE: ... tissue processing company, today announced,that it has ... Drug Administration,(FDA) for its CryoValve(R) SG pulmonary ... SynerGraft technology. CryoLife,s proprietary,SynerGraft technology is designed ...
... /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., (OTC Bulletin Board: VSCO), ... (TCM) based in Chengdu,China, today announced that Mr. ... will host a conference call to update shareholders ... conference call will take place at 4:15 p.m. ...
Cached Biology Technology:CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2
(Date:5/22/2013)... Bethesda, Md. (May 22, 2013)The omega 3 fatty acids ... against cardiovascular diseaseso much so that the American Heart ... fish a week, particularly fatty varieties rich in omega ... remains a mystery. In a new study, scientists led ... light on this phenomenon by providing evidence that fish ...
(Date:5/22/2013)... of potential environmental and human health effects from ... year has led scientists to recommend stronger government ... lithium-ion (Li-ion) battery materials. That,s the conclusion of ... Environmental Science & Technology . , Oladele A. ... have become mainstays for powering everything from smart ...
(Date:5/22/2013)... responsible for legionellosis, an infectious disease that can lead ... has developed a complex method enabling it to camouflage ... these acting against the infectious bacteria. , Research led ... which teams from the National Institute of Health (NIH) ... Barcelona (BSC) have also participated, has described for the ...
Breaking Biology News(10 mins):Fish oil may help the heart beat mental stress 2Mechanism discovered which aids Legionella to camouflage itself in the organism 2
... Anderson Cancer Center say they have jumped a significant hurdle ... to be the ultimate tool to both decode the function ... disease. , Reporting in the journal Genes and Development, ... approach to silence a selected gene in a specific tissue ...
... In the latest issue of the journal Nature, scientists ... (NIAID) of the National Institutes of Health (NIH) describe ... may lead to new ways of thinking about how ... vaccines. , Led by immunologist Ronald Germain, M.D., Ph.D., ...
... pig used for research at the University of Illinois ... provide the first sequence of the swine genome to ... million grant from the U.S. Department of Agriculture announced ... Lawrence B. Schook, a professor of animal sciences at ...
Cached Biology News:Tool developed to silence genes in specific tissues using RNAi 2Tool developed to silence genes in specific tissues using RNAi 3Chemical guidance of T cells leads to immunologic memory and long-term immunity 2Chemical guidance of T cells leads to immunologic memory and long-term immunity 3Illinois pig to make history as source of first complete swine genome 2
Sheep polyclonal to Methaqualone ( Abpromise for all tested applications). Antigen: Methaqualone(5') conjugated to BSA...
... Product Goat polyclonal to BRF2 ... terminal amino acids 406-419 of Human BRF2. ... yet tested in other species. Background Information ... of the RNA polymerase III transcription factor complex ...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: